Oncomine Precision Assay on the Ion Torrent Genexus System provides a complete NGS testing workflow that lets every lab go from specimen to report in a single day*. Now your laboratory can produce NGS results in the same time as testing for single-gene biomarkers like PD-L1.
Get a profile for 50 key genes in one day. See the complete picture by combining results for single-gene biomarkers like PD-L1 with other important biomarkers like BRAF, KRAS, ALK, NTRK, ROS1, and RET among others.
Oncomine Solutions offers the lowest sample input requirement of any NGS platform. Now you can submit more of your samples for testing and no longer need to deal with high test failure rates, even when tissue is very limited.
Get a clear and concise report that presents all relevant variants with annotated information about targeted therapies, medical guidelines, and enrollment in ongoing clinical trials.
Did you know that some NGS send-out labs have test failure rates of 20% due to high input requirements?
At that rate, 1 out of 5 samples do not receive a result, and many more are not tested at all due to lack of tissue availability.
Not with Oncomine Solutions. You can experience a sequencing success rate of over 95% because we only require 10ng of nucleic acid input. That means you can get an NGS result for more of the precious samples you have.
For Research Use Only. Not for use in diagnostic procedures. *Specimen-to-report workflow will be available after the Ion Torrent Genexus Purification System and integrated reporting capabilities are added in 2020.